Thus, GPER could prove to be a valuable anti-inflammatory target in chronic inflammatory diseases, including multiple sclerosis and Crohn’s disease/ulcerative colitis [126], as well as acute inflammation during viral infections. Here, GPER1 is linked to viral infectious disease.